Johns Hopkins ABX Guide
Sarecycline
INDICATIONS
FDA
FDA
- Treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in patients ≥ 9 years old
NON-FDA APPROVED USES
NON-FDA APPROVED USES
N/A
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: August 9, 2019
Citation
Bernice, Fidelia. "Sarecycline." Johns Hopkins ABX Guide, The Johns Hopkins University, 2019. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540714/all/Sarecycline.
Bernice F. Sarecycline. Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540714/all/Sarecycline. Accessed December 4, 2024.
Bernice, F. (2019). Sarecycline. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540714/all/Sarecycline
Bernice F. Sarecycline [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2019. [cited 2024 December 04]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540714/all/Sarecycline.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Sarecycline
ID - 540714
A1 - Bernice,Fidelia,Pharm.D.
Y1 - 2019/08/09/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540714/all/Sarecycline
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
